Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:51 am Sale |
2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Marshall Wace North America L.P. | 597,469 2.700% |
-625,783 (-51.16%) |
Filing History |
| 2023-05-22 4:15 pm Purchase |
2023-05-12 | 13G | InspireMD, Inc. NSPR |
Marshall Wace North America L.P. | 1,860,405 9.900% |
1,860,405 (New Position) |
Filing History |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Marshall Wace North America L.P. | 1,223,252 5.900% |
1,223,252 (New Position) |
Filing History |